VIC Fellows Spotlight: Sobha Pisharody, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

VIC Tech Expands National Footprint Establishing New Office in Minnesota

Physical presence taps into regional innovation across the upper Midwest Minneapolis-Saint Paul, MN – VIC Technology Venture Development (VIC) today announced that it has begun operations in Minnesota. Dr. Michael...

Dr. Wilbur Lam, Chief Medical Officer of Cellia Science, Elected to the National Academy of Medicine

Fayetteville, AR — Cellia Science, Inc. proudly announces that Dr. Wilbur Lam, MD, PhD, Chief Medical Officer and distinguished scientist in the field of diagnostics and biomedical engineering, has been elected to the...

Inside Pitt Innovation Institute with the Associate Director, Office of Industry & Economic Partnerships Paul-Valentin Pitou

Paul-Valentin joined the Office of Industry and Economic Partnerships in 2017, and currently manages industry and venture capital partnerships at the University of Pittsburgh. Prior, Paul-Valentin worked in the...

Solenic Medical Appoints Jose F. Guzman as Vice President of Strategic Marketing

ADDISON, TEXAS – On behalf of the Solenic team, we welcome Jose F. Guzman to the Solenic Medical team as Vice President of Strategic Marketing. Mr. Guzman has over 25 years of experience in product development, global...

Nob Hill Therapeutics Awarded HHS Phase II Grant for Lung Cancer Therapy

Nob Hill Therapeutics, a respiratory-focused healthcare company, will use the grant funds to develop an inhaled therapy to treat lung cancer. Albuquerque, NM - Nob Hill Therapeutics (NHT), a VIC Technology Venture...

Neurexis Therapeutics: New Discoveries Could Revolutionize Treatment of Alzheimer's and Other Neurological Conditions

Results published in the journal Nature confirm critical role of Calcium Calmodulin Kinase II (CaMKII) enzyme Aurora, CO - Neurexis Therapeutics, a biotechnology company committed to reshaping the landscape of...

The Genomic Revolution: Unveiling Personalized Medicine's Investment Potential

In healthcare, a paradigm shift is underway – one that promises to transform healthcare as we know it. The emergence of personalized medicine, fueled by groundbreaking advancements in genomics and diagnostics, can save...

Exploring the Clinical Applications of Virtual Reality in Healthcare

Background: While most people think of virtual reality as a source of entertainment, there are potential clinical applications of virtual reality. In this article, we will explore some of the most promising clinical...

FDA Breakthrough Device Designation for High Impact Medical Devices

Within the VIC Tech portfolio, SFC Fluidics and Solenic Medical have both announced FDA Breakthrough Device designation. But what is FDA Breakthrough Device designation and what benefits does it provide? From a...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Zebra Analytix